New Issue: Wells Fargo sells $2.38 million 15% enhanced yield notes on Vertex for Eksportfinans

By Susanna Moon

Chicago, Feb. 1 - Eksportfinans ASA priced $2.38 million of 15% annualized enhanced yield securities due Aug. 5, 2010 linked to the common stock of Vertex Pharmaceuticals Inc., according to an FWP filing with the Securities and Exchange Commission.

Wells Fargo Securities, LLC is the agent.

Interest is payable monthly.

The payout at maturity will be par unless Vertex stock falls by 30% or more during the life of the notes and finishes below the initial share price, in which case investors will receive a number of Vertex shares equal to $1,000 divided by the initial share price.

Issuer:	Eksportfinans ASA
Issue:	Enhanced yield securities
Underlying stock:	Vertex Pharmaceuticals Inc. (NYSE: VRTX)
Amount:	$2.38 million
Maturity:	Aug. 5, 2010
Coupon:	15%, payable monthly
Price:	Par
Payout at maturity:	If the stock falls to or below the knock-in price during the life of the notes and finishes below the initial price, 25.8732 Vertex shares; otherwise, par
Initial share price:	$38.65
Knock-in price:	$27.055, or 70% of initial price
Pricing date:	Jan. 28
Settlement date:	Feb. 2
Agent:	Wells Fargo Securities, LLC
Fees:	1.25%
Cusip:	282645UE8

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.